Kevin S.

Kevin S. has a diverse work experience in various roles and companies. kevin started their career as a Manager of Strategic Partnerships at Cadila Pharmaceuticals Limited from March 2011 to December 2014. From 2015 to 2017, they worked as a Consultant at Various Digital startups. In 2018, they joined Wellthy Therapeutics as a Vice President, and they stayed there until March 2020. Kevin then became an Investor at Goseeko in January 2019 and at Nexstem in May 2021. In September 2021, they became the Director of Business Development at Biofourmis. Subsequently, they worked as a Consultant at Curio Digital Therapeutics Inc. starting from March 2022. Currently, Kevin serves as an Advisor at Redesign Health starting from October 2023.

Kevin S. has a Master's degree in Healthcare Decision Analysis from the University of Southern California. Prior to that, they earned a Bachelor of Pharmacy (B.Pharm.) from Gujarat University. Additionally, they have obtained a Diploma in International Marketing from Ahmedabad Management Association, as well as participated in a Youth Development Program from the same institution.